Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 6/2018

Inhalt (20 Artikel)

Review – Cancer Research

Role of natural killer cells in lung cancer

Ozge Nur Aktaş, Ayşe Bilge Öztürk, Baran Erman, Suat Erus, Serhan Tanju, Şükrü Dilege

Original Article – Cancer Research

CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer

Soo Jung Lee, Sun-Young Jun, In Hee Lee, Byung Woog Kang, Su Yeon Park, Hye Jin Kim, Jun Seok Park, Gyu-Seog Choi, Ghilsuk Yoon, Jong Gwang Kim

Original Article – Cancer Research

Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy

Yiyang Wang, Difan Zheng, Jiajie Zheng, Qingyuan Huang, Baohui Han, Jie Zhang, Heng Zhao, Haiquan Chen

Open Access Original Article – Cancer Research

High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma

Abulajiang Abudureheman, Julaiti Ainiwaer, Zhichao Hou, Madiniyat Niyaz, Abdugheni Turghun, Ayshamgul Hasim, Haiping Zhang, Xiaomei Lu, Ilyar Sheyhidin

Original Article – Cancer Research

Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes

Peipei Lin, Yingwan Luo, Shuanghong Zhu, Dominic Maggio, Haiyang Yang, Chao Hu, Jinghan Wang, Hua Zhang, Yanling Ren, Xinping Zhou, Chen Mei, Liya Ma, Weilai Xu, Li Ye, Zhengping Zhuang, Jie Jin, Hongyan Tong

Original Article – Cancer Research

Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway

Ting-ting Liu, Xi-sheng Liu, Meng Zhang, Xue-ni Liu, Fu-xiang Zhu, Fang-ming Zhu, Si-wen Ouyang, Shan-bao Li, Chen-long Song, Hui-min Sun, Su Lu, Yu Zhang, Jun Lin, Hua-mei Tang, Zhi-hai Peng

Open Access Original Article – Cancer Research

Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia

Yunan Li, Mingying Zhang, Mengyao Sheng, Peng Zhang, Zizhen Chen, Wen Xing, Jie Bai, Tao Cheng, Feng-Chun Yang, Yuan Zhou

Original Article – Cancer Research

Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitors

Chenguang Li, Hailin Liu, Bin Zhang, Liqun Gong, Yanjun Su, Zhenfa Zhang, Changli Wang

Original Article – Cancer Research

A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim

Cornelius F. Waller, Renger G. Tiessen, Tracey E. Lawrence, Andrew Shaw, Mark Shiyao Liu, Rajiv Sharma, Mark Baczkowski, Mudgal A. Kothekar, Catherine E. Micales, Abhijit Barve, Gopinath M. Ranganna, Eduardo J. Pennella

Review – Clinical Oncology

Quality control and improvement of cancer care: what is needed? 4th European Roundtable Meeting (ERTM) May 5th, 2017, Berlin, Germany

Olaf Ortmann, Ulrike Helbig, Julie Torode, Stefan Schreck, Sakari Karjalainen, Manola Bettio, Ulrik Ringborg, Monika Klinkhammer-Schalke, Freddy Bray, Sakari Karjalainen, Manola Bettio, Stefan Schreck, Freddy Bray, Tit Albreht, Ulrik Ringborg, Julie Torode, Jan-Willem Coebergh, Sabine Siesling, Henrik Møller, Johannes Bruns, Markus Follmann, Ulrike Helbig, Andreas Hochhaus, Monika Klinkhammer-Schalke, Christoph Kowalski, Margarete Landenberger, Florian Lordick, Olaf Ortmann, Simone Wesselmann

Original Article – Clinical Oncology

Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival

Tanja Ignatov, Holm Eggemann, Elke Burger, Olaf Ortmann, Serban Dan Costa, Atanas Ignatov

Original Article – Clinical Oncology

Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients’ prognosis

Larissa Dettmar, Nancy Ahmed, Matthias Kotzsch, Sandra Diersch, Rudolf Napieralski, Dalila Darmoul, Manfred Schmitt, Wilko Weichert, Marion Kiechle, Julia Dorn, Viktor Magdolen

Original Article – Clinical Oncology

Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist’s perspective

Seo Hee Choi, Jee Suk Chang, Hong In Yoon, Dong-Su Jang, Nam Kyu Kim, Joon Seok Lim, Byung So Min, Hyuk Huh, Sang Joon Shin, Joong Bae Ahn, Woong Sub Koom

Original Article – Clinical Oncology

Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations

Silke Wemmert, Maximilian Linxweiler, Cornelia Lerner, Florian Bochen, Philipp Kulas, Johannes Linxweiler, Sigrun Smola, Steffi Urbschat, Stefan Wagenpfeil, Bernhard Schick

Original Article – Clinical Oncology

Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms

Yuki Mizuno, Atsushi Kudo, Takumi Akashi, Keiichi Akahoshi, Toshiro Ogura, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori, Daisuke Ban, Shinji Tanaka, Ukihide Tateishi, Minoru Tanabe

Original Article – Clinical Oncology

Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?

Khaled Elsayad, Laith Samhouri, Sergiu Scobioala, Uwe Haverkamp, Hans Theodor Eich

Original Article – Clinical Oncology

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma

Frank Heinzelmann, Wolfgang Bethge, Dietrich Wilhelm Beelen, Matthias Stelljes, Peter Dreger, Marianne Engelhard, Jürgen Finke, Nikolaus Kröger, Ernst Holler, Martin Bornhäuser, Annerose Müller, Imme Haubitz, Hellmut Ottinger

Open Access Original Article – Clinical Oncology

Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study

Ingo B. Runnebaum, Dietmar Reichert, Uta Ringsdorf, Markus Kuther, Tobias Hesse, Jalid Sehouli, Pauline Wimberger

Original Article – Clinical Oncology

MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach

Hans-Joachim Schmoll, Dirk Arnold, Aimery de Gramont, Michel Ducreux, Axel Grothey, Peter J. O’Dwyer, Eric Van Cutsem, Frank Hermann, Ivan Bosanac, Belguendouz Bendahmane, Christoph Mancao, Josep Tabernero

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.